Fedorova, Yu Yu,
Sagitova, A.V.,
Mingazheva, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Khusnutdinova, E.K.,
Darvish, M.,
Prokofyeva, D.S. (2024) from patients with an established diagnosis of ovarian
cancer and various histological and clinical
and in combination with cisplatin in a human ovarian
cancer xenograft model. Cisplatin was used as a comparator
With increasing incidence and geography,
cancer is one of the leading causes of death, reduced
Beylerli, Ozal,
Shi, Huaizhang,
Begliarzade, Sema,
Shumadalova, Alina,
Ilyasova, Tatiana,
Sufianov, Albert (2024) Brain metastases represent a formidable challenge in
cancer management, impacting a significant
: before, during, or long after the completion of
cancer treatment. Detailed clinical case studies of CNS
Wang, Chunlei,
Beylerli, Ozal,
Gu, Yan,
Xu, Shancai,
Ji, Zhiyong,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Chekhonin, Vladimir (2024) Background: Glioblastoma is the most common type of brain
cancer, with a prognosis